CareMax Enterprise Value Over E B I T D A from 2010 to 2024

CMAX Stock  USD 0.69  0.03  4.17%   
CareMax Enterprise Value Over EBITDA yearly trend continues to be fairly stable with very little volatility. Enterprise Value Over EBITDA is likely to outpace its year average in 2024. During the period from 2010 to 2024, CareMax Enterprise Value Over EBITDA regression line of annual values had significance of  0.03 and arithmetic mean of  17.27. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(0.82)
Current Value
(0.78)
Quarterly Volatility
20.5282438
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CareMax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CareMax's main balance sheet or income statement drivers, such as Interest Expense of 57.2 M, Minority Interest of 66.4 K or Depreciation And Amortization of 41.3 M, as well as many indicators such as Price To Sales Ratio of 0.0705, Dividend Yield of 0.0174 or PTB Ratio of 0.86. CareMax financial statements analysis is a perfect complement when working with CareMax Valuation or Volatility modules.
  
Check out the analysis of CareMax Correlation against competitors.
For more information on how to buy CareMax Stock please use our How to Invest in CareMax guide.

Latest CareMax's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of CareMax over the last few years. It is CareMax's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CareMax's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

CareMax Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean17.27
Coefficient Of Variation118.88
Mean Deviation14.88
Median26.99
Standard Deviation20.53
Sample Variance421.41
Range83.8987
R-Value(0.57)
Mean Square Error307.05
R-Squared0.32
Significance0.03
Slope(2.61)
Total Sum of Squares5,900

CareMax Enterprise Value Over E B I T D A History

2024 -0.78
2023 -0.82
2022 -42.47
2021 41.43
2020 17.15
2019 1.63

About CareMax Financial Statements

CareMax investors use historical fundamental indicators, such as CareMax's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CareMax. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA(0.82)(0.78)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CareMax Stock Analysis

When running CareMax's price analysis, check to measure CareMax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CareMax is operating at the current time. Most of CareMax's value examination focuses on studying past and present price action to predict the probability of CareMax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CareMax's price. Additionally, you may evaluate how the addition of CareMax to your portfolios can decrease your overall portfolio volatility.